Renpenning syndrome in a female

Renpenning syndrome (OMIM: 309500) is a rare X‐linked disorder that causes intellectual disability, microcephaly, short stature, a variety of eye anomalies, and characteristic craniofacial features. This condition results from pathogenic variation of PQBP1, a polyglutamine‐binding protein involved in transcription and pre‐mRNA splicing. Renpenning syndrome has only been reported in affected males. Carrier females do not usually have clinical features, and in reported families with Renpenning syndrome, most female carriers exhibit favorable skewing of X‐chromosome inactivation. We describe a female with syndromic features typical of Renpenning syndrome. She was identified by exome sequencing to have a de novo heterozygous c.459_462delAGAG mutation in PQBP1 (Xp11.23), affecting the AG hexamer in exon 4, which is the most common causative mutation in this syndrome. Streaky hypopigmentation of the skin was observed, supporting a hypothesized presence of an actively expressed, PQBP1 mutation‐bearing X‐chromosome in some cells. X‐inactivation studies on peripheral blood cells demonstrated complete skewing in both the proband and her mother with preferential inactivation of the maternal X chromosome in the child. We demonstrated expression of the PQBP1 mutant transcript in leukocytes of the affected girl. Therefore, it is highly likely that the PQBP1 mutation arose from the paternal X chromosome.

[1]  J. Lupski,et al.  Identification of Intellectual Disability Genes in Female Patients with a Skewed X‐Inactivation Pattern , 2016, Human mutation.

[2]  Junhai Han,et al.  X chromosome-linked intellectual disability protein PQBP1 associates with and regulates the translation of specific mRNAs. , 2015, Human molecular genetics.

[3]  M. Hřebíček,et al.  Identification of novel informative loci for DNA-based X-inactivation analysis. , 2015, Blood cells, molecules & diseases.

[4]  G. Thomsen,et al.  The splicing factor PQBP1 regulates mesodermal and neural development through FGF signaling , 2014, Development.

[5]  Z. Tümer,et al.  Three new loci for determining x chromosome inactivation patterns. , 2011, The Journal of molecular diagnostics : JMD.

[6]  J. Chelly,et al.  A novel frame shift mutation in the PQBP1 gene identified in a Tunisian family with X-linked mental retardation. , 2011, European journal of medical genetics.

[7]  L. Hertz-Pannier,et al.  The Renpenning syndrome spectrum: new clinical insights supported by 13 new PQBP1‐mutated males , 2011, Clinical genetics.

[8]  V. Kimonis,et al.  Mutation in PQBP1 is associated with periventricular heterotopia , 2010, American journal of medical genetics. Part A.

[9]  C. Romano,et al.  Common pathological mutations in PQBP1 induce nonsense‐mediated mRNA decay and enhance exclusion of the mutant exon , 2010, Human mutation.

[10]  R. Stevenson,et al.  Golabi-Ito-Hall syndrome results from a missense mutation in the WW domain of the PQBP1 gene , 2006, Journal of Medical Genetics.

[11]  L. Vallée,et al.  Exonic microdeletions in the X-linked PQBP1 gene in mentally retarded patients: a pathogenic mutation and in-frame deletions of uncertain effect , 2006, European Journal of Human Genetics.

[12]  R. Stevenson,et al.  Renpenning syndrome comes into focus , 2005, American journal of medical genetics. Part A.

[13]  M. Fichera,et al.  Skewed X‐inactivation in a family with mental retardation and PQBP1 gene mutation , 2005, Clinical genetics.

[14]  Matthias Platzer,et al.  Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. , 2004, American journal of human genetics.

[15]  Steffen Lenzner,et al.  Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation , 2003, Nature Genetics.

[16]  Carolyn J. Brown,et al.  Methylation of ZNF261 as an assay for determining X chromosome inactivation patterns , 2003, American journal of medical genetics. Part A.

[17]  W. Robinson,et al.  X‐chromosome inactivation (XCI) patterns in placental tissues of a paternally derived bal t(X;20) case , 2003 .

[18]  I. Kanazawa,et al.  Interaction between Mutant Ataxin-1 and PQBP-1 Affects Transcription and Cell Death , 2002, Neuron.

[19]  Carolyn J. Brown,et al.  Variability of X chromosome inactivation: effect on levels of TIMP1 RNA and role of DNA methylation , 2002, Human Genetics.

[20]  A. Sharp,et al.  Age- and tissue-specific variation of X chromosome inactivation ratios in normal women , 2000, Human Genetics.

[21]  R. Stevenson,et al.  Renpenning syndrome maps to Xp11. , 1998, American journal of human genetics.

[22]  H. Willard,et al.  An assay for X inactivation based on differential methylation at the fragile X locus, FMR1. , 1996, American journal of medical genetics.

[23]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.